Outcome of chemotherapy following nivolumab treatment for recurrent and/or metastatic head and neck squamous cell carcinoma

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 5.1K citations · Full text

Medicine, Oncology, Metastasis +5

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Jan B. Vermorken, Fernando Rivera, Éva Remenár et al. · New England Journal of Medicine · 2008 · 3.7K citations · Full text

Medicine, Oncology, Pharmacology +16

Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non–Small Cell Lung Cancer

Song Ee Park, Se‐Hoon Lee, Jin Seok Ahn et al. · Journal of Thoracic Oncology · 2017 · 247 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

Ricardo Hitt, H. Cortés-Funes, Juan J. Grau et al. · Annals of Oncology · 2011 · 222 citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer

Gustavo Schvartsman, S. Andrew Peng, Giorgios Bis et al. · Lung Cancer · 2017 · 219 citations

Medicine, Oncology, Pharmacology +17